How research can help the tiniest patients
Dr. Georg Schmӧlzer is currently leading a new national partnership to co-ordinate more neonatal clinical trials in Canada to improve outcomes for premature babies and their families.
Since 2013, Dr. Georg Schmölzer has been the recipient of 20 grants and awards from the Stollery Children’s Hospital Foundation through the Women and Children’s Health Research Institute (WCHRI).
Dr. Schmölzer is a neonatal physician, a professor in the Department of Pediatrics at the University of Alberta and the director of CSAR – the Centre for the Studies of Asphyxia and Resuscitation – a world-leading program that is unique in Canada.
With a focus on the resuscitation of newborn babies, PANDA, the Platform for Trials in Neonatal Care, launched in 2024 under the leadership of Dr.Schmӧlzer and with key support from the Foundation through WCHRI, which also provides clinical trials support to the network. PANDA Clinical Trials Network was established to conduct neonatal trials across Canada, while also building a lasting trial network for the future.
Resuscitation is needed for about one in every 1,000 babies who are delivered at term, and more often for those delivered preterm. Dr. Schmölzer’s current research explores a potentially safer and more controlled means of providing breathing support to preterm infants that could be implemented in the delivery room and lead to a reduction in negative health outcomes in these infants.
Thanks to your support, you’re helping fund life-saving research to improve outcomes and increase the chances of babies surviving neonatal resuscitation.
